Alterity Therapeutics Long Term Debt

Alterity Therapeutics (ATHE) currently reports a long-term debt of $65K as of December 2025. That compares with $43K in the prior-year period — up 51.7% year over year. Use the charts on this page to explore Alterity Therapeutics's long-term debt history and peer comparisons.

Alterity Therapeutics's long-term debt increased from $43K to $65K — a 51.7% year-over-year increase (period ending December 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Alterity Therapeutics reported $65K in long-term debt as of December 2025. That compares with $43K in the prior-year period — up 51.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $65K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Alterity Therapeutics, and consider following ATHE for alerts when major investors trade the stock.

Alterity Therapeutics is classified in the Healthcare sector. On long-term debt, it currently shows $65K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ATHE with unrelated industries.